These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7276560)

  • 1. Lack of binding of human C3, in its native state, to C3b receptors.
    Berger M; Gaither TA; Hammer CH; Frank MM
    J Immunol; 1981 Oct; 127(4):1329-34. PubMed ID: 7276560
    [No Abstract]   [Full Text] [Related]  

  • 2. Assay of membrane complement receptors (CR1 and CR2) with C3b- and C3d-coated fluorescent microspheres.
    Lambris JD; Ross GD
    J Immunol; 1982 Jan; 128(1):186-9. PubMed ID: 7033372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement receptors on Raji cells. The presence of a new type of C3 receptor.
    Okuda T; Tachibana T
    Immunology; 1980 Sep; 41(1):159-66. PubMed ID: 7429548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C3 modified at the thiolester site: acquisition of reactivity with cellular C3b receptors.
    Schreiber RD; Pangburn MK; Müller-Eberhard HJ
    Biosci Rep; 1981 Nov; 1(11):873-80. PubMed ID: 6458338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the human complement (c3b) receptor with a fluid phase C3b dimer.
    Arnaout MA; Melamed J; Tack BF; Colten HR
    J Immunol; 1981 Oct; 127(4):1348-54. PubMed ID: 7276561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative and quantitative assessment of C3-receptor reactivities on lymphoid and phagocytic cells.
    Schmitt M; Mussel HH; Dierich MP
    J Immunol; 1981 May; 126(5):2042-7. PubMed ID: 7217681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2.
    Molina H; Kinoshita T; Webster CB; Holers VM
    J Immunol; 1994 Jul; 153(2):789-95. PubMed ID: 8021513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of human complement component C3 with factor B and with complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) involve an acidic sequence at the N-terminus of C3 alpha'-chain.
    Taniguchi-Sidle A; Isenman DE
    J Immunol; 1994 Dec; 153(11):5285-302. PubMed ID: 7963581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement receptors on guinea pig epidermal Langerhans cells.
    Berman B; Gigli I
    J Immunol; 1980 Feb; 124(2):685-90. PubMed ID: 7356709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of soluble 125I-human C3b, the third component of complement, to specific receptors in human cultured B lymphoblastoids cells: characterization of a low affinity interaction.
    Frade R; Strominger J
    J Immunol; 1980 Sep; 125(3):1332-9. PubMed ID: 6967899
    [No Abstract]   [Full Text] [Related]  

  • 11. Maturation-linked expression of C3b and C3b' receptors on developing human bone marrow and peripheral blood granulocytes.
    Scott CS
    Clin Exp Immunol; 1981 Apr; 44(1):201-10. PubMed ID: 7261476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
    Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
    J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
    Sahu A; Kay BK; Lambris JD
    J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of complement in adherent immune complexes on Fc and C3 receptor expression in human monocytes.
    Arend WP; Massoni RJ
    Immunology; 1981 Dec; 44(4):717-25. PubMed ID: 7319557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of residues in the C3dg region of human complement component C3 corresponding to a proposed binding site for complement receptor type 2 (CR2, CD21) does not abolish binding of iC3b or C3dg to CR2.
    Diefenbach RJ; Isenman DE
    J Immunol; 1995 Mar; 154(5):2303-20. PubMed ID: 7868901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Babesia rodhaini interactions with complement: relationship to parasitic entry into red cells.
    Jack RM; Ward PA
    J Immunol; 1980 Apr; 124(4):1566-73. PubMed ID: 6767771
    [No Abstract]   [Full Text] [Related]  

  • 17. Structural insights into the central complement component C3.
    Janssen BJ; Gros P
    Mol Immunol; 2007 Jan; 44(1-3):3-10. PubMed ID: 16875735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage of the complement system C3 component by HIV-1 proteinase.
    Kisselev AF; Mentele R; von der Helm K
    Biol Chem; 1997 May; 378(5):439-42. PubMed ID: 9191031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fc and C3b receptors on cultured retinoblastoma cells.
    Stein PC; Rand N; Char DH
    Invest Ophthalmol Vis Sci; 1981 Oct; 21(4):550-3. PubMed ID: 7287344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.